Literature DB >> 6763340

Clinical evaluation of iron deficiency.

J D Cook.   

Abstract

While the prevalence of iron deficiency has remained relatively constant, there has been continuing refinement in its laboratory recognition, especially with the recent introduction of serum ferritin and FEP measurements. It is helpful to classify iron deficiency into three stages. Storage iron depletion is identified by marrow examination or serum ferritin, iron deficient erythropoiesis by TS, FEP, or MCV, and iron deficiency anemia by hemoglobin concentration or therapeutic iron trial. Combinations of these measurements have been used in prevalence studies to obtain a quantitative measure of body iron stores. The optimal laboratory approach to diagnosing iron deficiency depends on the clinical setting. In the office or outpatient clinic, iron depletion is best recognized by the serum ferritin, although the TS, FEP, and MCV are helpful in gauging its severity. In hospitalized patients with overt anemia, the TS, FEP, and MCV are much less helpful because similar changes are seen in the anemia of chronic disease. Examination of marrow iron remains the method of choice, especially in patients with infection, chronic disease, malignancy, or liver disease, although in many clinical situations the same information can be obtained from a serum ferritin. Serial measurements of serum ferritin have been particularly useful in monitoring patients at high risk of iron deficiency such as those with rheumatoid arthritis, chronic inflammatory bowel disease, or chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6763340

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  34 in total

Review 1.  Does this elderly patient have iron deficiency anaemia, and what is the underlying cause?

Authors:  O M Jolobe
Journal:  Postgrad Med J       Date:  2000-04       Impact factor: 2.401

2.  Functional iron deficiency during erythropoietin treatment.

Authors:  E G Anastassiades; J Howarth; H M Waters; K Hyde; R Gokal
Journal:  BMJ       Date:  1992-04-04

3.  Growth hormone replacement therapy in growth hormone deficient children and adults: Effects on hemochrome.

Authors:  S Bergamaschi; C Giavoli; E Ferrante; A Lania; R Rusconi; A Spada; P Beck-Peccoz
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

4.  Attitudes to prescribing iron supplements in general practice.

Authors:  D G Waller; A G Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-10

Review 5.  Case studies: iron.

Authors:  Sean Lynch
Journal:  Am J Clin Nutr       Date:  2011-07-06       Impact factor: 7.045

6.  Consequences of 6 weeks of strength training on red cell O2 transport and iron status.

Authors:  W Schobersberger; M Tschann; W Hasibeder; M Steidl; M Herold; W Nachbauer; A Koller
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

7.  Iron status in hypogammaglobulinaemia.

Authors:  H I Atrah
Journal:  J R Soc Med       Date:  1985-10       Impact factor: 5.344

Review 8.  Identification and treatment of anaemia in older patients.

Authors:  P T Murphy; R M Hutchinson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

9.  Association of insulin resistance with serum ferritin and aminotransferases-iron hypothesis.

Authors:  Jean Huang; Rudruidee Karnchanasorn; Horng-Yih Ou; Wei Feng; Lee-Ming Chuang; Ken C Chiu; Raynald Samoa
Journal:  World J Exp Med       Date:  2015-11-20

Review 10.  Iron requirements. Comments on methods and some crucial concepts in iron nutrition.

Authors:  L Hallberg
Journal:  Biol Trace Elem Res       Date:  1992-10       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.